every time i little research vagus nerve stimulation i find something new yet i nearly always count search yield results showing either corruption poor efficacy guess i found time i quote public citizen review vns literature vns device implanted beneath left clavicle outpatient procedure typically costs including device lead runs vagus nerve generates second electrical pulses every five minutes device approved refractory epilepsy cyberonics pursued additional indication trd perhaps company estimated market latter million people alone may letter fda urging agency approve device described inadequacies data supporting efficacy vns trd summarize data incorporate entire letter reference expecting demonstrate efficacy vns short term cyberonics conducted appropriately designed randomized controlled trial study acute phase three months duration trd patients implanted device half device turned half device turned received sham therapy study failure primary outcome measure hamilton rating scale depression hrsd vns showed efficacy compared sham therapy true nine ten secondary analyses remains best designed study vns date following study company offered sham therapy patients chance device turned study long term phase predictably patients improved time near ubiquitous finding studies depression patients due placebo effect tendency patients enrolled studies relapsing conditions improve time regression mean condition typically worse time enrollment times follow study patients unblinded unlike acute phase study permitted change concomitant therapies including antidepressants even electroshock therapy facing rejection application fda company opted add comparison group study merely compared study long term phase patients hastily assembled comparison group like study long term phase blinding concomitant therapies permitted change time comparison patients recruited overlapping different sites indeed authors published report vns acknowledge comparison arm originally intended serve control intended describe health care costs modest benefit reported researchers secondary outcome positive study hand picked primary outcome study moreover analysis mandated fda adjusting overlapping sites concomitant treatment produced statistically significant finding primary secondary outcome weaker package studies difficult imagine yet inconceivably fda issued approvable letter february approved device july overruling august non approvable letter fda sent company lot full document peruse suffice say shady course stop star academics like charles nemeroff signing vns therapy alleged wonders though several hundred publications belt stopped perhaps actually encouraged get involved chicanery related vns controversial treatments make academic psychiatry look good respected big name psychiatrists pimp treatments clearly provide little benefit